Mustang Bio, Inc.
NASDAQ:MBIO
0.248 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.225 | 3.031 | 2.306 | 1.785 | 1.368 | 0.63 | 0.002 | 0 | 0 |
| Gross Profit
| -2.225 | -3.031 | -2.306 | -1.785 | -1.368 | -0.63 | -0.002 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 39.18 | 63.949 | 55.706 | 47.301 | 36.315 | 24.464 | 20.376 | 8.547 | 4.044 |
| General & Administrative Expenses
| 9.686 | 12.21 | 11.017 | 9.505 | 9.57 | 6.759 | 11.409 | 2.816 | 0 |
| Selling & Marketing Expenses
| -0.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.321 | 12.21 | 11.017 | 9.505 | 9.57 | 6.759 | 11.409 | 2.816 | 0.254 |
| Other Expenses
| 0 | -1.304 | 5.842 | 10.064 | 6.273 | 3.36 | 12.433 | 6.079 | 0 |
| Operating Expenses
| 48.501 | 74.855 | 66.723 | 56.806 | 45.885 | 31.223 | 31.785 | 11.363 | 4.298 |
| Operating Income
| -50.726 | -76.159 | -66.723 | -56.806 | -45.885 | -31.223 | -31.785 | 11.363 | -4.298 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.876 | -1.366 | 0.353 | -3.209 | -0.504 | 0.561 | 0.497 | -0.159 | -0.168 |
| Income Before Tax
| -51.602 | -77.525 | -66.37 | -60.015 | -46.389 | -30.662 | -31.288 | -12.654 | -4.466 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 1.366 | -2.291 | 2.132 | 1.767 | 0.569 | 0.505 | 23.858 | 0 |
| Net Income
| -51.602 | -78.891 | -64.079 | -62.147 | -48.156 | -30.662 | -31.288 | -12.654 | -4.466 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -6 | -11.44 | -10.94 | -17.73 | -20.03 | -17.07 | -18.58 | -7.24 | -6.7 |
| EPS Diluted
| -6 | -11.44 | -10.94 | -17.73 | -20.03 | -17.07 | -18.58 | -7.24 | -6.7 |
| EBITDA
| -48.501 | -74.166 | -66.355 | -56.098 | -43.254 | -30.024 | -31.278 | -11.347 | -4.298 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |